<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="3241">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01997801</url>
  </required_header>
  <id_info>
    <org_study_id>SNUH_KEThyRobot</org_study_id>
    <nct_id>NCT01997801</nct_id>
  </id_info>
  <brief_title>Ketamine in Robot-assisted Thyroidectomy</brief_title>
  <acronym>KEThyRobot</acronym>
  <official_title>The Efficacy of Intraoperative Ketamine in Patients Undergoing Robot-assisted Thyroidectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <authority>Korea: Institutional Review Board</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this prospective double-blinded study, The investigators compared acute postoperative
      pain and rescue analgesic demand during postoperative period after robot thyroidectomy
      between ketamine and placebo groups.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Robot-assisted endoscopic thyroidectomy has been popularized due to cosmetic advantages.
      Despite small incisions, robot thyroidectomy did not offer satisfactory reduction in
      postoperative pain compared to open thyroidectomy. Ketamine is a non-competitive
      N-methyl-D-aspartate (NMDA) receptor blocker and takes some attractive advantages in terms
      of pain control. When low dose ketamine is perioperatively administrated, opioid sparing
      effect during postoperative period is reported in various surgical procedures such as spine,
      thoracic, and gynecologic surgery. Ketamine's beneficial effect on postoperative pain has
      not been investigated in patients undergoing robot thyroidectomy. The investigators
      hypothesized that perioperative ketamine administration can reduce acute postoperative pain
      after robot thyroidectomy and the incidence of chronic pain hypoesthesia on anterior chest
      at 3 months after surgery.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>December 2013</start_date>
  <completion_date type="Anticipated">December 2014</completion_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention</study_design>
  <primary_outcome>
    <measure>Pain at 24 hour postoperatively</measure>
    <time_frame>at 24 hour postoperatively</time_frame>
    <safety_issue>No</safety_issue>
    <description>Pain at 24 hour postoperatively will be evaluates using 11 point scale (0:no pain, 10:worst imaginable)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain at 3, 6, 12, 48 and 72 hour postoperatively</measure>
    <time_frame>at 3, 6, 12, 48 and 72 hour postoperatively</time_frame>
    <safety_issue>No</safety_issue>
    <description>Pain at 3, 6, 12, 48 and 72 hour postoperatively will be evaluated using 11-point scale 0:no pain, 10:worst imaginable)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to the first analgesics postoperatively</measure>
    <time_frame>At 24 hours postoperatively</time_frame>
    <safety_issue>No</safety_issue>
    <description>Time from the end of anesthesia till the first analgesic agent will be recorded at 24 hours postoperatively.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Analgesic requirements for 24 hours after surgery</measure>
    <time_frame>at 24 hours postoperatively</time_frame>
    <safety_issue>No</safety_issue>
    <description>Analgesic requirements for 24 hours after surgery will be evaluated.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Chronic pain at 3 month after surgery</measure>
    <time_frame>At 3 month after surgery</time_frame>
    <safety_issue>No</safety_issue>
    <description>Chronic pain at 3 month after surgery will be evaluated.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">64</enrollment>
  <condition>Thyroid</condition>
  <condition>Acute Pain</condition>
  <condition>Chronic Pain</condition>
  <arm_group>
    <arm_group_label>C group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>In C group, NS infusion will be done intraoperatively.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>KET group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In KET group, ketamine infusion will be done intraoperatively(0.25 mg/kg bolus injection following 100 mcg/kg/hr till the end of surgery).</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ketamine infusion</intervention_name>
    <description>Ketamine will be infused intraoperatively (0.25 mg/kg intravenous bolus following continuous infusion of 100 mcg/kg/hr).</description>
    <arm_group_label>KET group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>NS infusion</intervention_name>
    <description>Normal saline will be infused intraoperatively.</description>
    <arm_group_label>C group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients scheduled for robot-assisted thyroidectomy

          -  ASA I-III

        Exclusion Criteria:

          -  Patients with renal dysfunction

          -  Patients with hepatic dysfunction

          -  Patients with neurologic dysfunction

          -  Patients with the history of drug addiction

          -  Patients with chronic pain

          -  Patients who are allergic to ketamine

          -  Patients with increased ocular or intracranial pressure

          -  Patients with the risk of aspiration
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hee-Pyoung Park, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Seoul National University of Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hee-Pyoung Park, PhD</last_name>
    <phone>+82-10-2971-7647</phone>
    <email>hppark@snu.ac.kr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Hyun-Chang Kim, MD</last_name>
    <phone>+82-10-2886-2876</phone>
    <email>onidori1979@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>110-744</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Hee-Pyoung Park, PhD</last_name>
      <phone>+82-10-2971-7647</phone>
      <email>hppark@snu.ac.kr</email>
    </contact>
    <contact_backup>
      <last_name>Hyun-Chang Kim, MD</last_name>
      <phone>+82-10-2886-2876</phone>
      <email>onidori1979@gmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Hee-Pyoung Park, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>November 2013</verification_date>
  <lastchanged_date>November 24, 2013</lastchanged_date>
  <firstreceived_date>November 18, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Hospital</investigator_affiliation>
    <investigator_full_name>Hee-Pyoung Park</investigator_full_name>
    <investigator_title>Associate professor</investigator_title>
  </responsible_party>
  <keyword>Thyroidectomy</keyword>
  <keyword>Endoscopy</keyword>
  <keyword>Ketamine</keyword>
  <keyword>Acute Pain</keyword>
  <keyword>Chronic Pain</keyword>
  <keyword>Postoperative period</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Ketamine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
